Publications

Progressive hypofractionated carbon-ion radiotherapy for hepatocellular carcinoma: Combined analyses of 2 prospective trials.
Cancer 2017 Oct 29;123(20):3955-3965. Epub 2017 Jun 29.
Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.

Carbon-ion re-irradiation for recurrences after initial treatment of stage I non-small cell lung cancer with carbon-ion radiotherapy.
Radiother Oncol 2017 Oct 4;125(1):31-35. Epub 2017 Aug 4.
National Institute of Radiological Sciences Hospital, National Institutes for Quantum and Radiological Sciences and Technology, Chiba-shi, Japan.

A Multicenter Study of Carbon-Ion Radiation Therapy for Head and Neck Adenocarcinoma.
Int J Radiat Oncol Biol Phys 2017 Oct 3;99(2):442-449. Epub 2017 May 3.
Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Sciences and Technology, Chiba, Japan.

Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis.
Radiat Oncol 2017 Sep 2;12(1):144. Epub 2017 Sep 2.
National Institute of Radiological Sciences Hospital, National Institutes for Quantum and Radiological Sciences and Technology, 4-9-1, Anagawa, Inage-ward, Chiba, 263-8555, Japan.

Cancer-specific mortality of high-risk prostate cancer after carbon-ion radiotherapy plus long-term androgen deprivation therapy.
Cancer Sci 2017 Sep 16. Epub 2017 Sep 16.
Hospital of the National Institute of Radiological Sciences National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.

Evaluation of Risk Factors for Vertebral Compression Fracture after Carbon-Ion Radiotherapy for Primary Spinal and Paraspinal Sarcoma.
Biomed Res Int 2017 26;2017:9467402. Epub 2017 Jul 26.
Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

Multi-institutional retrospective study of mucoepidermoid carcinoma treated with carbon-ion radiotherapy.
Cancer Sci 2017 Jul 29;108(7):1447-1451. Epub 2017 May 29.
Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Sciences and Technology, Chiba, Japan.

Carbon-ion radiotherapy for patients with advanced stage non-small-cell lung cancer at multicenters.
J Radiat Res 2017 Jul 14:1-4. Epub 2017 Jul 14.
National Institute of Radiological Sciences Hospital, National Institutes for Quantum and Radiological Sciences and Technology, 4-9-1, Anagawa, Inage-ku, Chiba, Chiba 263-8555, Japan.

Prognostic factors of adenoid cystic carcinoma of the head and neck in carbon-ion radiotherapy: The impact of histological subtypes.
Radiother Oncol 2017 Jun 18;123(3):387-393. Epub 2017 May 18.
Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Sciences and Technology, Chiba, Japan.

Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
Radiat Oncol 2017 May 30;12(1):91. Epub 2017 May 30.
Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Sciences and Technology, 4-9-1 Anagawa, Inage Ward, Chiba City, Chiba Prefecture, Japan.

Dose escalation study with respiratory-gated carbon-ion scanning radiotherapy using a simultaneous integrated boost for pancreatic cancer: simulation with four-dimensional computed tomography.
Br J Radiol 2017 Apr 9;90(1072):20160790. Epub 2017 Feb 9.
1 Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.

Multicenter Study of Carbon-Ion Radiation Therapy for Mucosal Melanoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN).
Int J Radiat Oncol Biol Phys 2017 Apr 26;97(5):1054-1060. Epub 2016 Dec 26.
Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Sciences and Technology, Chiba, Japan.

The Immunoregulatory Potential of Particle Radiation in Cancer Therapy.
Front Immunol 2017 6;8:99. Epub 2017 Feb 6.
Trento Institute for Fundamental Physics and Applications-National Institute for Nuclear Physics (TIFPA-INFN), University of Trento, Trentino, Italy; Department of Physics, University Federico II, Naples, Italy.


Brain contrasting ability of blood-brain-barrier-permeable nitroxyl contrast agents for magnetic resonance redox imaging.
Magn Reson Med 2016 Sep 28;76(3):935-45. Epub 2015 Sep 28.
Department of Bio-functional Science, Faculty of Pharmaceutical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan.

PU-H71, a novel Hsp90 inhibitor, as a potential cancer-specific sensitizer to carbon-ion beam therapy.
J Radiat Res 2016 Sep 29;57(5):572-575. Epub 2016 May 29.
Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage, Chiba 263-8555, Japan Graduate School of Medical and Pharmaceutical Sciences, Chiba University, 1-8-1, Inohana, Chuo, Chiba 263-8522, Japan.




Single-Fraction Carbon-Ion Radiation Therapy for Patients 80 Years of Age and Older With Stage I Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys 2016 May 30;95(1):542-8. Epub 2015 Nov 30.
Research Center Hospital for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan.



A prospective nonrandomized phase I/II study of carbon ion radiotherapy in a favorable subset of locally advanced non-small cell lung cancer (NSCLC).
Cancer 2015 Apr 13;121(8):1321-7. Epub 2015 Jan 13.
Research Center Hospital for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan; Department of Radiology, The University of Tokyo Hospital, Tokyo, Japan.

Effects of targeted phosphorylation site mutations in the DNA-PKcs phosphorylation domain on low and high LET radiation sensitivity.
Oncol Lett 2015 Apr 17;9(4):1621-1627. Epub 2015 Feb 17.
Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO 80523, USA.

Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences, Japan.
Phys Med Biol 2015 Apr 31;60(8):3271-86. Epub 2015 Mar 31.
Medical Physics Research Group, Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.

Carbon-ion scanning lung treatment planning with respiratory-gated phase-controlled rescanning: simulation study using 4-dimensional CT data.
Radiat Oncol 2014 Nov 11;9:238. Epub 2014 Nov 11.
Research Center Hospital for Charged Particle Therapy, National Institute of Radiological Sciences, 4-9-1, Anagawa, Inage-ku, Chiba-shi, Chiba, 263-8555, Japan.



Health-related quality of life after carbon-ion radiotherapy for prostate cancer: a 3-year prospective study.
Int J Urol 2014 Apr 9;21(4):370-5. Epub 2013 Oct 9.
Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, Inage, Chiba, Japan; Gunma Heavy-ion Medical Center, Gunma University, Maebashi, Gunma, Japan.

Usefulness of J-CAPRA score for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapy.
Jpn J Clin Oncol 2014 Apr 28;44(4):360-5. Epub 2014 Feb 28.
*Department of Urology, Tokyo Kosei Nenkin Hospital, 5-1 Tsukudo-cho, Shinjuku-ku, Tokyo 162-8543, Japan.

Disproportionation of a 2,2-diphenyl-1-picrylhydrazyl radical as a model of reactive oxygen species catalysed by Lewis and/or Brønsted acids.
Chem Commun (Camb) 2014 Jan;50(7):814-6
Research Center for Charged Particle Therapy, National Institute of Radiological Sciences (NIRS), Inage-ku, Chiba 263-8555, Japan.



OF